Meeder Asset Management’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Meeder Asset Management’s Portfolio KRTX Stock Details KRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-2,613	Closed	-$827K	–	802
2023 Q4	$827K	Buy	+2,613	New	+$508K	0.06%	150
2021 Q4	–	Sell	-3	Closed	–	–	2464
2021 Q3	$0	Hold	3	–	–	﹤0.01%	2682
2021 Q2	$0	Hold	3	–	–	﹤0.01%	2712
2021 Q1	$0	Buy	+3	New	+$340	﹤0.01%	2491
2020 Q4	–	Sell	-10	Closed	-$1K	–	2303
2020 Q3	$1K	Sell	10 -9	-47%	-$767	﹤0.01%	2077
2020 Q2	$2K	Sell	19 -78	-80%	-$6.78K	﹤0.01%	1825
2020 Q1	$7K	Buy	+97	New	+$8.29K	﹤0.01%	1677

Other funds holding KRTX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Meeder Asset Management's KRTX Position: Q1 2024 in Review

Meeder Asset Management sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 2,613 shares — an estimated $827K sold.

Meeder Asset Management first reported a position in KRTX in Q1 2020 and held it in 7 quarters. The position peaked at $827K in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

Meeder Asset Management reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Meeder Asset Management sold 2,613 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $827K.
Meeder Asset Management first reported a position in Karuna Therapeutics, Inc. Common Stock in Q1 2020 and held it in 7 quarters.
Meeder Asset Management's Karuna Therapeutics, Inc. Common Stock position peaked at $827K in Q4 2023.
2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Meeder Asset Management's 13F filing for Q1 2024, filed 7 May 2024.